24/7 Patient Assistance: 760-405-8205

Christopher Jahraus, MD

Radiation Oncologist

Write a review
Doctor's profile photo

Request a call back

Conditions Treated Laryngeal Cancer Lung Cancer Ovarian Cancer Pleural Mesothelioma Testicular Mesothelioma

specialties & services

  • Bio & Insurance Information

    Dr. Christopher Jahraus is a specialist in radiation oncology in Alabaster, Alabama and he is working in collaboration with many local hospitals, such as Shelby Baptist Medical Center and Southeast Alabama Medical Center. He finished the classes of University of Alabama School of Medicine where he got his medical degree. He did training in biology at Bethel College, St. Paul, MN. He also did an internship in pediatrics at St. Louis Children’s Hospital. After this, the doctor did his residency program in radiation oncology at University of Kentucky College of Medicine. He is board certificated in radiation oncology. Dr. Christopher Jahraus has a practical experience of more than 20 years.

  • Education & Training


    University of Alabama School of Medicine

    Medical School


    St Louis Children\'s Hospital



    University of Kentucky College of Medicine


  • Board Certifications

    American Board of Internal Medicine - Oncology

    American Board of Radiology - Radiation Oncology

  • Hospital & Practice

    Shelby Baptist Medical Center

    Languages: English/Spanish

    (205) 620-8100

    1000 1st St N

    Alabaster, Alabama 35007

    Read More

    Southeast Alabama Medical Center

    Languages: English/Spanish

    (334) 793-8111

    1108 Ross Clark Cir

    Dothan, Alabama 36301

    Read More

    Vaughan Regional Medical Center

    Languages: English/Spanish

    (334) 418-4100

    1015 Medical Center Pkwy

    Selma, Alabama 36701

    Read More
  • Publications & Memberships

    Dr. Christopher Jahraus has contributed to 3 publications.

    Chemopotentiation by ultrafractionated radiotherapy in glioblastoma resistant to conventional therapy.

    Jahraus, C. D., Friedman, A. H.; Tumori. 2010 Sep-Oct.

    See more >>

    Rifaximin diminishes neutropenia following potentially lethal whole-body radiation.

    Jahraus, C. D., Schemera, B., Rynders, P., Ramos, M., Powell, C., Faircloth, J., Brawner, W. R.; Exp Biol Med (Maywood). 2010 Jul.

    See more >>

    Optic pathway gliomas.

    Jahraus, C.D., Tarbell, N.J.; Pediatr Blood Cancer. 2006 May 1.

    See more >>


    American Society for Radiation Oncology

    American Society of Clinical Oncology